Counterfeits quantified

$75 billion. That's an estimate of the revenue generated in the 2010 counterfeit drug market, according to The Center for Medicine in the Public Interest. The center's president, former FDA associate commissioner Peter Pitts, bases the figure on government information. He projects growth of 20% annually in the coming years. News